Showing results (351-360 of 1,945) with videos related to
Sort By:
Pageof 195
RMD Open|August 29, 2024
Clinical, biological, prognostic characteristics of patients with immune-mediated thrombotic thrombocytopenic purpura and Sjögren's diseaseJustine Luciano, Laurent Gilardin, Gaétane Nocturne, et al.RMD Open|August 23, 2024
Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritisYoshiya Tanaka, Yusuke Miyazaki, Masafumi Kawanishi, et al.RMD Open|November 8, 2024
Remission versus low disease activity as treatment targets in rheumatoid arthritis: how to strike the right balance between too strict and too lenient targets? A meta-epidemiological study of individual patient dataCatia Duarte, Johannes W G Jacobs, Ricardo J O Ferreira, et al.RMD Open|November 18, 2024
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profileSilvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.RMD Open|November 18, 2024
Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritisSara Turcinov, Ravi Kumar Sharma, Charlotte De Vries, et al.RMD Open|November 13, 2024
Immune checkpoint molecules performance in ANCA vasculitisPaula Anton-Pampols, Laura Martinez Valenzuela, Loreto Fernandez Lorente, et al.RMD Open|November 13, 2024
Routine radiographs of hands and feet do not have diagnostic or prognostic value in patients with clinically suspect arthralgia: a large longitudinal studyQuirine A Dumoulin, Annette H M van der Helm-van Mil, Hanna W van SteenbergenRMD Open|November 7, 2024
Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-γR/STAT1 pathway in the treatment of rheumatoid arthritisYao Teng, Haifeng Yin, Ruizhi Feng, et al.RMD Open|July 22, 2024
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody responseMikhail Volkov, Arieke S B Kampstra, Karin A J van Schie, et al.RMD Open|July 25, 2024
Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYONDRonald F van Vollenhoven, Stephen Hall, Alvin F Wells, et al.Pageof 195